Stryker Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 9/6/2026)
| Balance Sheet | Total Assets | 47,844,000,000.00 | ROE | 46.86 % |
| Balance Sheet | Total Equity | 22,420,000,000.00 | ROA | 6.78 % |
| Cashflow | Capital Expenditures | -761,000,000.00 | P/FCF | 25.13 |
| Cashflow | Free Cash Flow | 4,283,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 5,044,000,000.00 | P/CF | 21.34 |
| Income | Earnings per Share (diluted) | 8.49 | Div. Yield | 1.21 % |
| Income | Net Income | 3,246,000,000.00 | P/E | 33.17 |
| Income | Shares Outstanding | 382,200,000.00 | P/B | 4.80 |
| Income | Total Revenue | 25,116,000,000.00 | P/S | 4.29 |
Ratios calculated on: 10/14/2026
Company Description
Stryker Corporation (Stryker) is a medical technology company. Stryker offers a diverse array of medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products. The Company operates in three business segments: Reconstructive, MedSurg, and Neurotechnology and Spine. Its products include implants used in joint replacement, trauma, and spinal surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment, as well as other medical device products used in a variety of medical specialties. Internationally, its products are sold in over 100 countries through Company-owned sales subsidiaries and branches, as well as third-party dealers and distributors. In 2012, the Company completed the acquisition of Surpass Medical, Ltd. (Surpass). Effective March 1, 2013, Stryker Corp acquired the share capital of Trauson Holdings Co Ltd.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.stryker.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more